Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Howard

Showing results (551-560 of 569) with videos related to

Pageof 57
Sort By:
Children'S Health Care : Journal of the Association for the Care of Children'S Health|September 20, 2016
School-based Screening to Identify Children At Risk for Attention-Deficit/Hyperactivity Disorder: Barriers and ImplicationsTammy D Barry, Raymond A Sturner, Karen Seymour, et al.
Journal of Surgical Oncology|September 28, 2018
A novel, simplified, externally validated staging system for truncal/extremity soft tissue sarcomas: An analysis of the US Sarcoma Collaborative databaseAileen C Johnson, Cecilia G Ethun, Yuan Liu, et al.
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|July 14, 2026
Advances in the development of N-acylbenzo[d][1,2,3]diazaborinin-1(2H)-ols as antibacterial agents by synthesis, characterization, and antimicrobial assayChloe A Woods, Betty Gutierrez, Naidine Aguinaldo, et al.
Bioorganic & Medicinal Chemistry|June 16, 2016
Identification of cellular targets of a series of boron heterocycles using TIPA II-A sensitive target identification platformMatthew S Ward, Isba Silva, Walfre Martinez, et al.
Science (New York, N.Y.)|March 7, 2024
Accounting for the increasing benefits from scarce ecosystemsM A Drupp, M C Hänsel, E P Fenichel, et al.
BMC Public Health|March 26, 2014
A systematic review of special events to promote breast, cervical and colorectal cancer screening in the United StatesCam Escoffery, Kirsten C Rodgers, Michelle C Kegler, et al.
Pharmacology Research & Perspectives|March 26, 2019
Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's diseaseFernando L Pagan, Michaeline L Hebron, Barbara Wilmarth, et al.
JAMA Neurology|December 17, 2019
Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical TrialFernando L Pagan, Michaeline L Hebron, Barbara Wilmarth, et al.
Journal of Clinical Pharmacology|July 24, 2015
Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemiaJeremie H Estepp, Chiara Melloni, Courtney D Thornburg, et al.
Pediatric Hematology and Oncology|March 6, 2010
Design of the silent cerebral infarct transfusion (SIT) trialJames F Casella, Allison A King, Bruce Barton, et al.
Pageof 57

Showing results (551-560 of 569) with videos related to

Sort By:
Pageof 57
Children'S Health Care : Journal of the Association for the Care of Children'S Health|September 20, 2016
School-based Screening to Identify Children At Risk for Attention-Deficit/Hyperactivity Disorder: Barriers and ImplicationsTammy D Barry, Raymond A Sturner, Karen Seymour, et al.
Journal of Surgical Oncology|September 28, 2018
A novel, simplified, externally validated staging system for truncal/extremity soft tissue sarcomas: An analysis of the US Sarcoma Collaborative databaseAileen C Johnson, Cecilia G Ethun, Yuan Liu, et al.
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|July 14, 2026
Advances in the development of N-acylbenzo[d][1,2,3]diazaborinin-1(2H)-ols as antibacterial agents by synthesis, characterization, and antimicrobial assayChloe A Woods, Betty Gutierrez, Naidine Aguinaldo, et al.
Bioorganic & Medicinal Chemistry|June 16, 2016
Identification of cellular targets of a series of boron heterocycles using TIPA II-A sensitive target identification platformMatthew S Ward, Isba Silva, Walfre Martinez, et al.
Science (New York, N.Y.)|March 7, 2024
Accounting for the increasing benefits from scarce ecosystemsM A Drupp, M C Hänsel, E P Fenichel, et al.
BMC Public Health|March 26, 2014
A systematic review of special events to promote breast, cervical and colorectal cancer screening in the United StatesCam Escoffery, Kirsten C Rodgers, Michelle C Kegler, et al.
Pharmacology Research & Perspectives|March 26, 2019
Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's diseaseFernando L Pagan, Michaeline L Hebron, Barbara Wilmarth, et al.
JAMA Neurology|December 17, 2019
Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical TrialFernando L Pagan, Michaeline L Hebron, Barbara Wilmarth, et al.
Journal of Clinical Pharmacology|July 24, 2015
Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemiaJeremie H Estepp, Chiara Melloni, Courtney D Thornburg, et al.
Pediatric Hematology and Oncology|March 6, 2010
Design of the silent cerebral infarct transfusion (SIT) trialJames F Casella, Allison A King, Bruce Barton, et al.
Pageof 57